An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells
article
OA: bronze
CC0
⤵ 60 in-corpus citations
AI-generated summary
This paper investigated potential epigenetic dysregulation leading to abnormal aromatase gene expression within endometriotic stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo examine the molecular basis of aromatase expression in stromal cell culture from endometriotic chocolate cysts.DesignProspective study.SettingDepartment of Obstetrics and Gynecology and Department of Biosignaling, Tottori University, Yonago Japan.Patient(s)Thirty women, selected randomly, who underwent laparoscopy (n = 18) or laparotomy (n = 12).Intervention(s)Endometrial and endometriotic stromal cells were obtained from the uterus and chocolate cyst lining of the ovary.Main outcome measure(s)Estradiol concentrations in the culture media were measured by means of enzyme immunoassay. Aromatase expression was examined by quantitative real-time polymerase chain reaction. Promoter usage was examined using unique exon I (PII, I.1, I.3, I.4, I.5, and I.6) and exon II primers. To determine the effect of 5-aza-deoxycytidine on endometrial stromal cells, the cells were treated with the agent for 96 hours.Result(s)Endometriotic cells secreted a marginal level of estradiol into the culture media, but adding testosterone to the culture produced a pronounced level of estradiol. In endometrial cells, estradiol production was far less efficient than in endometriotic cells even after adding testosterone. Real-time polymerase chain reaction analyses demonstrated the up-regulation of aromatase messenger RNA (mRNA) expression in endometriotic cells. Three proximal promoters, PII, 1.3, and 1.6, drove mRNA expression. In endometrial cells where a marginal level of aromatase mRNA expression was observed, the same promoters as those in the endometriotic cells were used. To determine the role of epigenetic modification of aromatase gene expression in endometriotic cells, endometrial cells were treated with 5-aza-deoxycytidine, which markedly enhanced aromatase mRNA expression, depending on the same proximal promoters as those in endometriotic cells.Conclusion(s)An epigenetic disorder may play a role in the pathophysiology of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- Aromatase expression in endometriosis. via openalex
- Drug-induced apoptosis was markedly attenuated in endometriotic stromal cells via openalex
- Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. via openalex
- Expression of Aromatase Cytochrome P450 Protein and Messenger Ribonucleic Acid in Human Endometriotic and Adenomyotic Tissues but not in Normal Endometrium1 via openalex
- Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex
- Pathogenetic Significance of Increased Levels of Interleukin-8 in the Peritoneal Fluid of Patients with Endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Role of cytokines in endometriosis via openalex
- Spatially Heterogenous Expression of Aromatase P450 through Promoter II Is Closely Correlated with the Level of Steroidogenic Factor-1 Transcript in Endometrioma Tissues via openalex
- Stimulation of Aromatase P450 Promoter (II) Activity in Endometriosis and Its Inhibition in Endometrium Are Regulated by Competitive Binding of Steroidogenic Factor-1 and Chicken Ovalbumin Upstream Promoter Transcription Factor to the Same cis-Acting Element via openalex
- Tumor Necrosis Factor-α-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably through Nuclear Factor-κB Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression via openalex
- W2125788271 via openalex
- W2042642675 via openalex
- W2024819383 via openalex
- W2170546016 via openalex
- W2417044776 via openalex
- W4229706584 via openalex
- W4229809477 via openalex
- W4243180786 via openalex
- W6656356435 via openalex
- W6661376251 via openalex
- W6661823845 via openalex
- W6675112554 via openalex
- W2046387526 via openalex
- W6811379631 via openalex
- W2050729293 via openalex
- W2054823635 via openalex
- W2099423538 via openalex
- W2045226350 via openalex
Cited by (50)
- A Systematic Review of Epigenetics of Endometriosis 2024
- Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis 2023
- Translational aspects of the endometriosis epigenome 2023
- DNA methylation profiles of ovarian cysts resemble ovarian tissues, but not endometrial tissues 2023
- Investigating Post-translational Changes of Histones, DNA Methylation Level, and ERβ Protein Level in the Cumulus Cell Genome of Infertile Women with Endometriosis 2023
- Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis 2023
- Aberrant expression of histone deacetylase 8 in endometriosis and its potential as a therapeutic target 2023
- Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis 2023
- Global endometrial DNA methylation analysis reveals insights into mQTL regulation and associated endometriosis disease risk and endometrial function 2023
- Epigenetic regulation and T-cell responses in endometriosis - something other than autoimmunity 2022
- Global Endometrial DNA Multi-omics Analysis Reveals Insights into mQTL Regulation and Associated Endometriosis Disease Risk 2022
- Aberrant epigenetic regulation of estrogen and progesterone signaling at the level of endometrial/endometriotic tissue in the pathomechanism of endometriosis 2022
- Estrogen- and Progesterone (P4)-Mediated Epigenetic Modifications of Endometrial Stromal Cells (EnSCs) and/or Mesenchymal Stem/Stromal Cells (MSCs) in the Etiopathogenesis of Endometriosis 2021
- The Pathogenesis of Adenomyosis vis-à-vis Endometriosis 2020
- Effect of<scp>epigallocatechin‐3‐gallate</scp>on the status of<scp>DNA</scp>methylation of E‐cadherin promoter region on endometriosis mouse 2020
- The Genetic Background of Endometriosis: Can ESR2 and CYP19A1 Genes Be a Potential Risk Factor for Its Development? 2020
- Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells 2020
- An Analysis of <i>ESR2</i> and <i>CYP19A1</i> Gene Expression Levels in Women With Endometriosis 2020
- Polymorphisms in the 3<a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:msup> <a:mrow/> <a:mrow> <a:mo>′</a:mo> </a:mrow> </a:msup> </a:math>UTR Region of ESR2 and CYP19A1 Genes and Its Influence on Allele-Specific Gene Expression in Endometriosis 2020
- ATM expression is attenuated by promoter hypermethylation in human ovarian endometriotic stromal cells 2019
- Translational Aspects of the Endometriosis Epigenome 2018
- GATA6 expression promoted by an active enhancer may become a molecular marker in endometriosis lesions 2018
- Epigenetic regulation of the pathological process in endometriosis 2017
- Lipopolysaccharide promotes the development of murine endometriosis‐like lesions via the nuclear factor‐kappa B pathway 2017
- SR-16234, a Novel Selective Estrogen Receptor Modulator for Pain Symptoms with Endometriosis: An Open-label Clinical Trial. 2017
- Estrogen Biosynthesis and Its Regulation in Endometriosis 2017
- Aberrant Methylation of the E-Cadherin Gene Promoter Region in Endometrium and Ovarian Endometriotic Cysts of Patients with Ovarian Endometriosis 2016
- Endometriosis-Search for Biomarkers 2016
- DNA methylation in endometriosis (Review) 2016
- Molecular Biology of Endometriosis 2016
- Differential expression of upstream stimulatory factor (USF) 2 variants in eutopic endometria from women with endometriosis: estradiol regulation 2015
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells 2015
- Aberrant expression and localization of deoxyribonucleic acid methyltransferase 3B in endometriotic stromal cells 2015
- A current view of the role of epigenetic changes in the aetiopathogenesis of endometriosis 2015
- Molecular Background of Estrogen Receptor Gene Expression in Endometriotic Cells 2015
- DNA methylation of HOXA10 in eutopic and ectopic endometrium 2014
- Role of Aromatase Inhibitors in the Treatment of Endometriosis 2014
- Genome-Wide DNA Methylation Profiling in Cultured Eutopic and Ectopic Endometrial Stromal Cells 2014
- The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis 2014
- Epigenetics in Endometriosis 2014
- Aromatase Expression in Endometriosis and Its Significance 2014
- Genetic, epigenetic and stem cell alterations in endometriosis: new insights and potential therapeutic perspectives 2013
- Regression of Experimentally Induced Endometriosis with a New Selective Cyclooxygenase-2 Enzyme Inhibitor 2013
- Structural and molecular features of the endomyometrium in endometriosis and adenomyosis 2013
- Epigenetic aberration of gene expression in endometriosis 2013
- The Epigenetics of Endometriosis 2012
- Genetic Polymorphisms of DNMT3L Involved in Hypermethylation of Chromosomal Ends Are Associated with Greater Risk of Developing Ovarian Endometriosis 2012
- Histone deacetylase inhibitors as therapeutics for endometriosis 2012
- Pathogenesis: Epigenetics 2011
- Are aromatase inhibitors effective in endometriosis treatment? 2011
Source provenance
- europepmc
- last seen: 2026-09-30T06:18:36.089610+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:54.534439+00:00
License: CC0
· commercial use OK